foxo4-dri senolytic animal model 2023 2024 The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series JACC: Basic to Translational Science ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram PDF) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI
Pay in 4 interest-free payments of $7.19 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





